News & Media

Take a look inside our world

Feature stories

Teva sets ambitious long-term environmental goals

Teva sets ambitious long-term environmental goals

‘It has made a real difference’: Increasing access to medicines in Haiti

‘It has made a real difference’: Increasing access to medicines in Haiti

Rise of the Superbugs: 5 Key Questions Answered

Rise of the Superbugs: 5 Key Questions Answered

COVID-19 puts medicine supply security in Europe's spotlight

COVID-19 puts medicine supply security in Europe's spotlight

‘Biosimilars are advancing more treatment options for patients’

‘Biosimilars are advancing more treatment options for patients’

‘Half the world’s people lack access to medicines’

‘Half the world’s people lack access to medicines’

‘I’ve seen the impact that asthma and COPD can have’

‘I’ve seen the impact that asthma and COPD can have’

‘Patients who relied on their medicine before COVID19 rely on them just as much today.’

‘Patients who relied on their medicine before COVID19 rely on them just as much today.’

Helping Healthcare Services Resume

Helping Healthcare Services Resume

Meet Mike Smith

Meet Mike Smith
View all stories

Press Releases

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal...

Teva Announces Launch of a Generic Version of NuvaRing® (etonogestrel and ethinyl estradiol) Vaginal Ring

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva Sets Ambitious Long-Term Environmental Goals As Part of Renewed ESG Strategy

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Gui...

Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva to Present at the 39th Annual J.P. Morgan Healthcare Conference

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Rele...

Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release S

Teva Reports Third Quarter 2020 Financial Results

Teva Reports Third Quarter 2020 Financial Results

Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio

Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio

Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for ...

Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY

Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir di...

Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disopro

Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on Novembe...

Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5,
View all press releases
Previous
Next

Connect with us on social media


Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

+972-3-9187869
Yonatan.Beker@tevapharm.com

Smadar Tabenkin-Ezer

Corporate Communications International Markets

+972-3-9062305
Smadar.Tabenkin-Ezer01@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com